A comprehensive health-screening program in rural northern KwaZulu-Natal, South Africa, has found a high burden of undiagnosed or poorly controlled non-communicable diseases, according to a study published in The Lancet Global Health.
Academics from the London Centre for Nanotechnology at UCL (University College London) and AHRI used deep learning (artificial intelligence/AI) algorithms to improve health workers' ability to diagnose HIV using lateral flow tests in rural South Africa.
Researchers have designed a device that delivers two medications that help stop HIV transmission.
What The Study Did: In this survey study, COVID-19 was associated with large reductions in economic security among women at high risk of HIV infection in Kenya. However, shifts in sexual behavior may have temporarily decreased their risk of HIV infection.
Individuals infected with HIV are more than twice as likely to die from sudden cardiac death (SCD) compared to the general population, and are more likely to have hearts compromised by fibrosis, a factor that may play a role in increasing their susceptibility to SCD, according to new findings from a UC San Francisco study.
The annual number of new HIV infections among men who have sex with men in England is likely to have fallen dramatically, from 2,770 in 2013 to 854 in 2018, showing elimination of HIV transmission by 2030 to be within reach -- suggests work by researchers from the MRC Biostatistics Unit at the University of Cambridge and Public Health England, published in The Lancet HIV.
Forty years ago, the first cases of HIV/AIDS in the US began to raise public awareness -- but new research highlights the struggle people living with the disease still face against stigma, discrimination and negative labelling in their own families, communities and even amongst healthcare professionals.
The experimental, lab-made antibody leronlimab can completely prevent nonhuman primates from being infected with the monkey form of HIV, new research published in Nature Communications shows. The results will inform a future human clinical trial evaluating leronlimab as a potential pre-exposure prophylaxis, or PrEP, therapy to prevent human infection from the virus that causes AIDS.
A phase III clinical trial led by an investigator at the Medical University of South Carolina found that a novel four-month regimen was just as effective at treating tuberculosis as the standard six-month regimen. The findings are reported in the May 6, 2021 New England Journal of Medicine.
People who use methamphetamine are more likely to have health conditions, mental illness, and substance use disorders than people who do not use the drug, according to a new study by researchers at the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU School of Global Public Health.